granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses
entitled to attend Extraordinary General Meeting of Shareholders No. 1/2017 (Record Date) on October 24, 2017 and to empower the Executive Committee or the Managing Director to amend or change the date of
as directors to the company. The trust instrument shall require the selection of the said individuals to be approved by the trust manager’s board of directors; (2) specifying the responsibilities of
shall comply with the following rules: (1) shall make consideration of credit rating information selection with responsibility and caution (fiduciary duties) and shall not make credit rating information
credit rating information selection with responsibility and caution (fiduciary duties) and shall not make credit rating information selection which may cause assets of clients to be in a condition of low
นรวมฟดเดอร (Feeder Fund) กองทุนรวมที่เนนลงทุนแบบมีความเสี่ยงตางประเทศ กลุม Global Equity นโยบายและกลยุทธการลงทุน เนนลงทุนในหนวยลงทุนของกองทุน Schroder International Selection Fund Global Energy
CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 Q1’19 Q4’19 Q1’20 change change Btmn Btmn Btmn y-on-y q-on-q Sales and service income 10,257 11,258 11,223 9.4% (0.3%) EBITDA* 2,413 2,938 3,278 35.8% 11.6% Net